Real-time PCR quantification of AT1 and AT2 angiotensin receptor mRNA expression in the developing rat kidney. 2003

Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84132-2204, USA.

OBJECTIVE Angiotensin II (Ang II) is an important growth factor in the fetal kidney. Molecular cloning and pharmacological studies have defined two major classes of Ang II receptors designated AT1 and AT2. Two AT1 isoforms, AT1A and AT1B, exist in rodents. AT1 promotes growth and proliferation and mediates many of the known physiological actions of Ang II. AT2 appears to antagonize AT1. Our goal was to measure their relative contributions to Ang II signaling in the developing kidney. METHODS We used real-time RT-PCR to quantify AT1A, AT1B, AT2 and the housekeeping gene EF1alpha mRNA in kidneys from embryonic (E) day 14-20 and postnatal (P) day 1-14 rats. RESULTS AT2 mRNA declined from 1.4 x 10(4) copies/10(6) copies EF1alpha on E14 to 4.2 x 10(3) copies/10(6) copies EF1alpha on P14. In contrast, total AT1 mRNA increased gradually from 2.0 x 10(3) copies/10(6) copies EF1alpha on E14 to 2.0 x 10(4) copies/10(6) copies EF1alpha on P14, with AT1A accounting for about 90% of total AT1 mRNA throughout nephrogenesis. Moreover, the ratio of AT2/(AT1A + AT1B) decreased in a log-linear fashion during maturation, from 6.7 on E14 to 0.2 on P14. CONCLUSIONS The ratio of AT2 to AT1 gene expression modulates Ang II action in the developing kidney.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003199 Computer Systems Systems composed of a computer or computers, peripheral equipment, such as disks, printers, and terminals, and telecommunications capabilities. Computer Architecture,Computer System,Computer Systems Development,Computer Systems Evaluation,Computer Systems Organization,Real Time System,Real-Time Systems,Organization, Computer Systems,Architecture, Computer,Architectures, Computer,Computer Architectures,Computer Systems Evaluations,Development, Computer Systems,Evaluation, Computer Systems,Evaluations, Computer Systems,Real Time Systems,Real-Time System,System, Computer,System, Real Time,System, Real-Time,Systems, Computer,Systems, Real Time,Systems, Real-Time,Time System, Real,Time Systems, Real
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D044139 Receptor, Angiotensin, Type 2 An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR. Angiotensin II Type 2 Receptor,Angiotensin Type 2 Receptor,Receptor, Angiotensin II Type 2,Angiotensin AT2 Receptor,AT2 Receptor, Angiotensin,Receptor, Angiotensin AT2

Related Publications

Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
September 1999, The American journal of physiology,
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
May 1995, The American journal of physiology,
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
March 1997, Circulation,
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
October 1994, Kidney international,
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
May 1998, Cardiovascular research,
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
November 1997, Hypertension (Dallas, Tex. : 1979),
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
May 2005, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
October 2001, The Journal of biological chemistry,
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
January 2004, Acta biochimica Polonica,
Pilar García-Villalba, and Nathaniel D Denkers, and Carl T Wittwer, and Charles Hoff, and Raoul D Nelson, and Teri Jo Mauch
July 1991, The American journal of physiology,
Copied contents to your clipboard!